Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04595409
Brief Title: A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis (VESPUCCI)

First Submitted : October 14, 2020
First Submitted that Met QC Criteria : October 14, 2020
First Posted : October 20, 2020

Last Update Submitted that Met QC Criteria : October 14, 2020
Last Update Posted : October 20, 2020